| The impact of the COVID-19 pandemic on cancer care M Richards, M Anderson, P Carter, BL Ebert, E Mossialos Nature Cancer 1 (6), 565-567, 2020 | 541 | 2020 |
| Health information technology and digital innovation for national learning health and care systems A Sheikh, M Anderson, S Albala, B Casadei, BD Franklin, M Richards, ... The Lancet Digital Health 3 (6), e383-e396, 2021 | 193 | 2021 |
| Covid-19 exposes weaknesses in European response to outbreaks M Anderson, M Mckee, E Mossialos Bmj 368, 2020 | 128 | 2020 |
| Securing a sustainable and fit-for-purpose UK health and care workforce M Anderson, C O'Neill, JM Clark, A Street, M Woods, C Johnston-Webber, ... The Lancet 397 (10288), 1992-2011, 2021 | 105 | 2021 |
| Health system, public health, and economic implications of managing COVID-19 from a cardiovascular perspective P Carter, M Anderson, E Mossialos European heart journal 41 (27), 2516-2518, 2020 | 94 | 2020 |
| A governance framework for development and assessment of national action plans on antimicrobial resistance M Anderson, K Schulze, A Cassini, D Plachouras, E Mossialos The Lancet Infectious Diseases 19 (11), e371-e384, 2019 | 94 | 2019 |
| LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19 M Anderson, E Pitchforth, M Asaria, C Brayne, B Casadei, A Charlesworth, ... The Lancet 397 (10288), 1915-1978, 2021 | 85 | 2021 |
| Developing a sustainable exit strategy for COVID-19: health, economic and public policy implications M Anderson, M Mckee, E Mossialos Journal of the Royal Society of Medicine 113 (5), 176-178, 2020 | 76 | 2020 |
| Averting the AMR crisis: What are the avenues for policy action for countries in Europe? M Anderson, C Clift, K Schulze, A Sagan, S Nahrgang, E Mossialos | 62 | 2019 |
| Digital health paradox: international policy perspectives to address increased health inequalities for people living with disabilities R van Kessel, R Hrzic, E O'Nuallain, E Weir, BLH Wong, M Anderson, ... Journal of medical Internet research 24 (2), e33819, 2022 | 55 | 2022 |
| Beyond gross domestic product for New Zealand's wellbeing budget M Anderson, E Mossialos The Lancet Public Health 4 (7), e320-e321, 2019 | 52 | 2019 |
| The changing health needs of the UK population M McKee, K Dunnell, M Anderson, C Brayne, A Charlesworth, ... The Lancet 397 (10288), 1979-1991, 2021 | 39 | 2021 |
| Building the economic case for primary health care: a scoping review EM M Anderson, S Albala, N Patel, J Lloyd https://apps.who.int/iris/bitstream/handle/10665/326293/WHO-HIS-SDS-2018.60 …, 2018 | 35* | 2018 |
| After Astana: building the economic case for increased investment in primary health care H Kluge, E Kelley, S Swaminathan, N Yamamoto, S Fisseha, ... The Lancet 392 (10160), 2147-2152, 2018 | 34 | 2018 |
| Challenges to tackling antimicrobial resistance: economic and policy responses M Anderson, M Cecchini, E Mossialos Cambridge University Press, 2020 | 31* | 2020 |
| A review of NICE appraisals of pharmaceuticals 2000–2016 found variation in establishing comparative clinical effectiveness M Anderson, H Naci, D Morrison, L Osipenko, E Mossialos Journal of clinical epidemiology 105, 50-59, 2019 | 29 | 2019 |
| United Kingdom: health system review M Anderson, E Pitchforth, N Edwards, H Alderwick, A McGuire, ... World Health Organization. Regional Office for Europe, 2022 | 28 | 2022 |
| Navigating the role of the EU Health Emergency Preparedness and Response Authority (HERA) in Europe and beyond M Anderson, R Forman, E Mossialos The Lancet Regional Health–Europe 9, 2021 | 27 | 2021 |
| What is the right level of spending needed for health and care in the UK? A Charlesworth, M Anderson, C Donaldson, P Johnson, M Knapp, ... The Lancet 397 (10288), 2012-2022, 2021 | 21 | 2021 |
| Ensuring access and affordability through COVID-19 vaccine research and development investments: a proposal for the options market for vaccines R Forman, M Anderson, M Jit, E Mossialos Vaccine 38 (39), 6075, 2020 | 20 | 2020 |
